BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22875837)

  • 1. Whole-exome sequencing identifies mutations in the nucleoside transporter gene SLC29A3 in dysosteosclerosis, a form of osteopetrosis.
    Campeau PM; Lu JT; Sule G; Jiang MM; Bae Y; Madan S; Högler W; Shaw NJ; Mumm S; Gibbs RA; Whyte MP; Lee BH
    Hum Mol Genet; 2012 Nov; 21(22):4904-9. PubMed ID: 22875837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerosing bone dysplasias with hallmarks of dysosteosclerosis in four patients carrying mutations in SLC29A3 and TCIRG1.
    Howaldt A; Nampoothiri S; Quell LM; Ozden A; Fischer-Zirnsak B; Collet C; de Vernejoul MC; Doneray H; Kayserili H; Kornak U
    Bone; 2019 Mar; 120():495-503. PubMed ID: 30537558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopetrosis: Gene-based nosology and significance Dysosteosclerosis.
    Turan S
    Bone; 2023 Feb; 167():116615. PubMed ID: 36402365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution of sclerotic lesions of dysosteosclerosis due to biallelic SLC29A3 variant in a Turkish girl.
    Uludağ Alkaya D; Akpınar E; Bilguvar K; Tüysüz B
    Am J Med Genet A; 2021 Jul; 185(7):2271-2277. PubMed ID: 33837634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the phenotypic spectrum of TNFRSF11A-associated dysosteosclerosis: a case with intracranial extramedullary hematopoiesis.
    Xue JY; Simsek-Kiper PO; Utine GE; Yan L; Wang Z; Taskiran EZ; Karaosmanoglu B; Imren G; Gocmen R; Nishimura G; Matsumoto N; Miyake N; Ikegawa S; Guo L
    J Hum Genet; 2021 Jun; 66(6):607-611. PubMed ID: 33402699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysosteosclerosis presents as an "osteoclast-poor" form of osteopetrosis: comprehensive investigation of a 3-year-old girl and literature review.
    Whyte MP; Wenkert D; McAlister WH; Novack DV; Nenninger AR; Zhang X; Huskey M; Mumm S
    J Bone Miner Res; 2010 Nov; 25(11):2527-39. PubMed ID: 20499338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysosteosclerosis: Clinical and Radiological Evolution Reflecting Genetic Heterogeneity.
    Turan S; Mumm S; Alavanda C; Kaygusuz BS; Gurpinar Tosun B; Arman A; Huskey M; Guran T; Duan S; Bereket A; Whyte MP
    JBMR Plus; 2022 Aug; 6(8):e10663. PubMed ID: 35991533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel homozygous frame-shift mutation in the SLC29A3 gene: a new case report and review of literature.
    Noavar S; Behroozi S; Tatarcheh T; Parvini F; Foroutan M; Fahimi H
    BMC Med Genet; 2019 Aug; 20(1):147. PubMed ID: 31464584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of two novel mutations in SLC29A3 encoding an equilibrative nucleoside transporter (hENT3) in two distinct Syrian families with H syndrome: expression studies of SLC29A3 (hENT3) in human skin.
    Farooq M; Moustafa RM; Fujimoto A; Fujikawa H; Abbas O; Kibbi AG; Kurban M; Shimomura Y
    Dermatology; 2012; 224(3):277-84. PubMed ID: 22653152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease.
    Morgan NV; Morris MR; Cangul H; Gleeson D; Straatman-Iwanowska A; Davies N; Keenan S; Pasha S; Rahman F; Gentle D; Vreeswijk MP; Devilee P; Knowles MA; Ceylaner S; Trembath RC; Dalence C; Kismet E; Köseoğlu V; Rossbach HC; Gissen P; Tannahill D; Maher ER
    PLoS Genet; 2010 Feb; 6(2):e1000833. PubMed ID: 20140240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal High Bone Mass With First Mutation of the NF-κB Complex: Heterozygous De Novo Missense (p.Asp512Ser) RELA (Rela/p65).
    Frederiksen AL; Larsen MJ; Brusgaard K; Novack DV; Knudsen PJ; Schrøder HD; Qiu W; Eckhardt C; McAlister WH; Kassem M; Mumm S; Frost M; Whyte MP
    J Bone Miner Res; 2016 Jan; 31(1):163-72. PubMed ID: 26178921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: Osteosclerotic metaphyseal dysplasia with optic nerve involvement and progressive osteonecrosis of the jaw due to a novel LRRK1 mutation.
    Pieridou C; Sabir A; Lancashire J; Liang Y; McMillan K; Shaw N; Uday S
    Front Endocrinol (Lausanne); 2023; 14():1258340. PubMed ID: 37920250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The third case of TNFRSF11A-associated dysosteosclerosis with a mutation producing elongating proteins.
    Xue JY; Wang Z; Smithson SF; Burren CP; Matsumoto N; Nishimura G; Ikegawa S; Guo L
    J Hum Genet; 2021 Apr; 66(4):371-377. PubMed ID: 33037392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mild form of SLC29A3 disorder: a frameshift deletion leads to the paradoxical translation of an otherwise noncoding mRNA splice variant.
    Bolze A; Abhyankar A; Grant AV; Patel B; Yadav R; Byun M; Caillez D; Emile JF; Pastor-Anglada M; Abel L; Puel A; Govindarajan R; de Pontual L; Casanova JL
    PLoS One; 2012; 7(1):e29708. PubMed ID: 22238637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult Osteosclerotic Metaphyseal Dysplasia With Progressive Osteonecrosis of the Jaws and Abnormal Bone Resorption Pattern Due to a LRRK1 Splice Site Mutation.
    Howaldt A; Hennig AF; Rolvien T; Rössler U; Stelzer N; Knaus A; Böttger S; Zustin J; Geißler S; Oheim R; Amling M; Howaldt HP; Kornak U
    J Bone Miner Res; 2020 Jul; 35(7):1322-1332. PubMed ID: 32119750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations.
    Guerrini MM; Sobacchi C; Cassani B; Abinun M; Kilic SS; Pangrazio A; Moratto D; Mazzolari E; Clayton-Smith J; Orchard P; Coxon FP; Helfrich MH; Crockett JC; Mellis D; Vellodi A; Tezcan I; Notarangelo LD; Rogers MJ; Vezzoni P; Villa A; Frattini A
    Am J Hum Genet; 2008 Jul; 83(1):64-76. PubMed ID: 18606301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysosteosclerosis is also caused by TNFRSF11A mutation.
    Guo L; Elcioglu NH; Karalar OK; Topkar MO; Wang Z; Sakamoto Y; Matsumoto N; Miyake N; Nishimura G; Ikegawa S
    J Hum Genet; 2018 Jun; 63(6):769-774. PubMed ID: 29568001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic intrafamilial variability including H syndrome and Rosai-Dorfman disease associated with the same c.1088G > A mutation in the SLC29A3 gene.
    Chouk H; Ben Rejeb M; Boussofara L; Elmabrouk H; Ghariani N; Sriha B; Saad A; H'Mida D; Denguezli M
    Hum Genomics; 2021 Oct; 15(1):63. PubMed ID: 34657628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exome sequencing identifies CTSK mutations in patients originally diagnosed as intermediate osteopetrosis.
    Pangrazio A; Puddu A; Oppo M; Valentini M; Zammataro L; Vellodi A; Gener B; Llano-Rivas I; Raza J; Atta I; Vezzoni P; Superti-Furga A; Villa A; Sobacchi C
    Bone; 2014 Feb; 59():122-6. PubMed ID: 24269275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of biallelic LRRK1 mutations in osteosclerotic metaphyseal dysplasia and evidence for locus heterogeneity.
    Iida A; Xing W; Docx MK; Nakashima T; Wang Z; Kimizuka M; Van Hul W; Rating D; Spranger J; Ohashi H; Miyake N; Matsumoto N; Mohan S; Nishimura G; Mortier G; Ikegawa S
    J Med Genet; 2016 Aug; 53(8):568-74. PubMed ID: 27055475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.